Figure 5From: Potential of recombinant inorganic pyrophosphatase antigen as a new vaccine candidate against Baylisascaris schroederi in miceNumbers of B. schroederi larvae recovered from livers, lungs or both in mice vaccinated with r Bsc -PYP-1 coupled with FCA. Mice were vaccinated three times subcutaneously and then inoculated orally with 3200 B. schroederi infective embryonated eggs at 1 week (trial II) or 2 weeks (trial I) after the final vaccination, as described in Materials and Methods. Mice were sacrificed at 1 wpc, and the migrating larvae were recovered from livers or lungs. The results are expressed as the mean ± SD in each group of 10 mice. Asterisks indicate that the mean value was significantly lower than that of the group vaccinated with PBS plus FCA or PBS alone (*P < 0.05, **P < 0.01, ***P < 0.001). NS denotes no statistically significant difference, and the error bars indicate SD.Back to article page